Renal artery stenosis in heart failure
Captopril, an oral angiotensin-converting enzyme inhibitor, has proven to be effective in the management of congestive heart failure (CHF). 1 Several trials have documented short- and long-term hemodynamic and clinical improvement with captopril therapy, including increased exercise tolerance. 2,3 H...
Saved in:
Published in | The American journal of cardiology Vol. 62; no. 17; pp. 1307 - 1308 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
01.12.1988
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Captopril, an oral angiotensin-converting enzyme inhibitor, has proven to be effective in the management of congestive heart failure (CHF).
1 Several trials have documented short- and long-term hemodynamic and clinical improvement with captopril therapy, including increased exercise tolerance.
2,3 However, captopril may fail to improve or be detrimental to renal function
4 in some patients, particularly if accompanied by marked decreases in systemic pressures. Recent reports have described captopril-induced renal insufficiency in patients with bilateral renal artery stenosis or unilateral stenosis in a solitary kidney
5 and in renal transplant recipients with hypertension.
6 Herein we describe certain findings in 6 of 89 patients with significant CHF seen in a 10-month period in whom a diagnosis of significant renal artery stenosis was made. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0002-9149 1879-1913 |
DOI: | 10.1016/0002-9149(88)90283-4 |